Proteomic, miRNA and bacterial biomarker patterns in atopic dermatitis patients and their course upon anti‐IL‐4Rα therapy

Identification of biomarkers is required for a systems medicine approach and personalized treatment in atopic dermatitis (AD). These biomarkers may not only aid in diagnosing but also might be suitable to predict the effectiveness of targeted treatment.